Pearls from the EGS Guidelines
Publishing date: May 2020
Pearls Manager: Andrew Tatham
Individualized glaucoma treatment aims at providing glaucoma management tailored to the individual needs of the patient; patients with severe functional loss or younger patients with manifest disease should have more aggressive treatment and closer follow up than patients at low risk, e.g. patients with ocular hypertension or elderly patients with mild field loss and low IOP.
EGS Guidelines, 4th edition, Page 133.
Leske MC, Heijl A, Hyman L, et al. Predictors or long-term progression in the early manifest glaucoma trial. Ophthalmology 2007;114(11):1965-72.
The Advanced Glaucoma Intervention Study (AGIS): 12. Baseline risk factors for sustained loss of visual field and visual acuity in patients with advanced glaucoma. Am J Ophthalmol 2002;134 (4):499-512.